Lisata Therapeutics, Inc.
LSTA
$2.26
$0.17568.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.34% | -4.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.49% | -3.39% | |||
| Operating Income | 7.25% | 3.39% | |||
| Income Before Tax | 6.49% | 2.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.49% | 2.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.49% | 2.26% | |||
| EBIT | 7.25% | 3.39% | |||
| EBITDA | 7.29% | 3.36% | |||
| EPS Basic | 7.32% | 2.40% | |||
| Normalized Basic EPS | 3.29% | 2.42% | |||
| EPS Diluted | 7.32% | 2.87% | |||
| Normalized Diluted EPS | 3.29% | 2.42% | |||
| Average Basic Shares Outstanding | 0.89% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.89% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||